Back
Open Access

When do we need to anticoagulate in subclinical atrial fibrillation?

Session: New Developments in Atrial Fibrillation, a Global Effort to Reduce the Burden of Cardiovascular Disease
Topic: Atrial Fibrillation (AF)
Speaker: Doctor T. Glotzer (Hackensack, US)
Event: ESC CONGRESS 2020 - The Digital Experience

Congress Session

0

About the speaker

Doctor Taya Glotzer

Hackensack University Medical Center, Hackensack (United States of America)
5 presentations
0 follower

2 more presentations in this session

Left atrial occluders in the world of NOAC.

Speaker: Professor M. Glikson (Jerusalem, IL)

Access
Slides
Video
0
Thumbnail

Introducing an update to the WHF Roadmap on atrial fibrillation: a truly global effort.

Speaker: Professor S. Freedman (Sydney, AU)

Access
Slides
Video
0
Thumbnail

Access the full session

New Developments in Atrial Fibrillation, a Global Effort to Reduce the Burden of Cardiovascular Disease

Speakers: Doctor T. Glotzer, Professor M. Glikson, Professor S. Freedman
Access
0
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

Congress
logo Image

Related content

Open Access

Expanding therapeutic options for lowering LDL-c: Where will bempedoic acid and inclisiran contribute.

27 August 2021

Open Access

Key point in tricuspid Valve Imaging.

27 August 2021

Open Access

How to grade severity of tricuspid regurgitation.

27 August 2021

This platform is supported by

logo Novo Nordisk